The Interaction of Histone Deacetylase Inhibitors and DNA Methyltransferase Inhibitors in the Treatment of Human Cancer Cells
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
187-199
Author(s):
Wei-Guo Zhu and Gregory A. Otterson
Signal Transduction Inhibitors in the Treatment of Breast Cancer
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
201-216
Author(s):
Rita Nahta, Gabriel N. Hortobagyi and Francisco J. Esteva
Peroxisome Proliferator Activated Receptor-Gamma Ligands as Potent Antineoplastic Agents
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
239-251
Author(s):
S. Theocharis, A. Margeli and G. Kouraklis
TGF-ß / Smad Signaling in Prostate Cancer
Journal:
Current Drug Targets
Volume:
4
Page:
197-207
Author(s):
Diana Bello-DeOcampo and Donald J. Tindall
Antisense Targets to Enhance Hormone and Cytotoxic Therapies in Advanced Prostate Cancer
Journal:
Current Drug Targets
Volume:
4
Page:
209-221
Author(s):
Martin Gleave, Colleen Nelson and Kim Chi
Par-4 for Molecular Therapy of Prostate Cancer
Journal:
Current Drug Targets
Volume:
4
Page:
223-230
Author(s):
James Butler and Vivek M. Rangnekar
From TGF-β to Cancer Therapy
Journal:
Current Drug Targets
Volume:
4
Page:
243-250
Author(s):
Xuemei Huang and Chung Lee
Energy Dependent Transport of Xenobiotics and Its Relevance to Multidrug Resistance
Journal:
Current Cancer Drug Targets
Volume:
3
Page:
89-107
Author(s):
Rajendra Sharma, Yogesh C. Awasthi, Yusong Yang, Abha Sharma, Sharad S. Singhal and Sanjay Awasthi
Survivin: Role in Normal Cells and in Pathological Conditions
Journal:
Current Cancer Drug Targets
Volume:
3
Page:
131-152
Author(s):
L. O'Driscoll, R. Linehan and M. Clynes
Induction of Senescent-Like Growth Arrest as a New Target in Anticancer Treatment
Journal:
Current Cancer Drug Targets
Volume:
3
Page:
153-159
Author(s):
Xianghong Wang, Sai-Wah Tsao, Yong-Chuan Wong and Annie L.M. Cheung